Announcements
- The Board of Director's decision to issue convertible loans
- Bestyrelsens beslutning om udstedelse af konvertible lån
- Konsolideret delårsrapport 1. januar – 31. marts 2024
- Consolidated interim report 1 January – 31 March 2024
- Afsøgning af muligheder angående en rettet kapitalforhøjelse til markedskurs i Pharma Equity Group A/S
- Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S
- Indkaldelse til ekstraordinær generalforsamling i Pharma Equity Group A/S
- Notice convening the extraordinary general meeting of Pharma Equity Group A/S
- Storaktionærmeddelelse - Pharma Equity Group A/S
- Major shareholder announcement - Pharma Equity Group A/S
More ▼
Key statistics
SmartText not available for this item.
52-week range
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 2.00 |
Average volume | -- |
---|---|
Shares outstanding | 1.02bn |
Free float | 1.01bn |
P/E (TTM) | -- |
Market cap | 209.71m DKK |
EPS (TTM) | -0.0234 DKK |
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼